HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Szekeres Selected Research

Adipokines

1/2020A Multidisciplinary Intervention in Childhood Obesity Acutely Improves Insulin Resistance and Inflammatory Markers Independent From Body Composition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas Szekeres Research Topics

Disease

38Neoplasms (Cancer)
10/2017 - 04/2002
21Leukemia
10/2017 - 04/2002
15Breast Neoplasms (Breast Cancer)
01/2022 - 07/2005
5Inflammation (Inflammations)
04/2023 - 01/2011
4Liver Diseases (Liver Disease)
04/2023 - 01/2021
4Pancreatic Neoplasms (Pancreatic Cancer)
10/2013 - 02/2008
4Colonic Neoplasms (Colon Cancer)
02/2009 - 04/2002
3Portal Hypertension
04/2023 - 01/2021
3Heart Diseases (Heart Disease)
10/2022 - 06/2010
3Myocardial Infarction
10/2022 - 10/2007
3Stroke (Strokes)
10/2022 - 01/2019
3Heart Failure
10/2021 - 10/2007
3Melanoma (Melanoma, Malignant)
03/2015 - 06/2010
3Neoplasm Metastasis (Metastasis)
03/2015 - 07/2013
3Carcinoma (Carcinomatosis)
11/2012 - 07/2005
2Critical Illness (Critically Ill)
03/2024 - 10/2007
2Fibrosis (Cirrhosis)
04/2023 - 12/2021
2COVID-19
03/2023 - 12/2021
2Cardiovascular Diseases (Cardiovascular Disease)
10/2022 - 01/2019
2Coronary Artery Disease (Coronary Atherosclerosis)
10/2022 - 01/2019
2Pulmonary Embolism
10/2021 - 10/2007
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
08/2015 - 01/2015
2Coronary Disease (Coronary Heart Disease)
06/2012 - 01/2008
2Lymphoma (Lymphomas)
03/2009 - 07/2005
2Glioma (Gliomas)
10/2004 - 04/2002
2Leukemia L1210
08/2004 - 04/2002
1Hemolysis
03/2024
1End Stage Liver Disease
04/2023
1Acute-On-Chronic Liver Failure
04/2023
1Brain Neoplasms (Brain Tumor)
01/2022
1Kidney Diseases (Kidney Disease)
10/2021
1Thrombosis (Thrombus)
10/2021
1Wounds and Injuries (Trauma)
10/2021

Drug/Important Bio-Agent (IBA)

19ResveratrolIBA
03/2015 - 03/2005
15Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
10/2017 - 08/2002
14Cytarabine (Cytosar-U)FDA LinkGeneric
10/2017 - 08/2002
7DNA (Deoxyribonucleic Acid)IBA
01/2018 - 03/2005
6Hormones (Hormone)IBA
10/2021 - 09/2007
6EnzymesIBA
10/2013 - 04/2002
4Biomarkers (Surrogate Marker)IBA
04/2023 - 01/2020
4C-Reactive ProteinIBA
04/2023 - 01/2020
4Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2011 - 01/2007
43,3',4,4',5,5'-hexahydroxystilbeneIBA
06/2010 - 09/2006
4StilbenesIBA
06/2010 - 10/2006
4Floxuridine (FUdR)FDA LinkGeneric
07/2005 - 09/2003
3Gallic AcidIBA
01/2018 - 01/2007
3Antineoplastic Agents (Antineoplastics)IBA
10/2017 - 04/2002
3Proteins (Proteins, Gene)FDA Link
08/2015 - 10/2009
3digalloylresveratrolIBA
10/2013 - 02/2009
3Phosphates (Orthophosphate)IBA
06/2012 - 08/2004
33,3',4,5'-tetrahydroxystilbeneIBA
12/2010 - 09/2006
3AvemarIBA
03/2009 - 02/2005
3AntioxidantsIBA
08/2008 - 09/2006
2AldosteroneIBA
12/2021 - 10/2021
2ReninIBA
12/2021 - 10/2021
2Brain Natriuretic Peptide (Natrecor)FDA Link
10/2021 - 10/2007
2pro-brain natriuretic peptide (1-76)IBA
10/2021 - 01/2009
2Natriuretic PeptidesIBA
10/2021 - 10/2007
2Messenger RNA (mRNA)IBA
08/2015 - 03/2010
2Anaplastic Lymphoma KinaseIBA
08/2015 - 01/2015
2PolyphenolsIBA
01/2015 - 10/2009
2triphosphoric acid (triphosphate)IBA
01/2015 - 12/2010
2Sulfates (Sulfates, Inorganic)IBA
09/2014 - 03/2010
2GemcitabineFDA Link
11/2012 - 02/2008
2Estrogens (Estrogen)FDA Link
09/2012 - 12/2010
2SulfotransferasesIBA
03/2010 - 03/2008
2Fluorouracil (Carac)FDA LinkGeneric
02/2009 - 08/2004
2CytidineIBA
02/2009 - 03/2005
23'-C-methyladenosineIBA
07/2008 - 07/2005
2Deuterium Oxide (Heavy Water)IBA
02/2008 - 09/2005
23,4,5-trihydroxybenzamidoximeIBA
02/2006 - 08/2002
2tiazofurinIBA
03/2005 - 04/2002
2Carmustine (FIVB)FDA Link
10/2004 - 08/2004
23,4-dihydroxybenzohydroxamic acidIBA
10/2004 - 08/2004
23-(1-deoxyribofuranosyl)benzamideIBA
04/2002 - 04/2002
1Hemoglobins (Hemoglobin)IBA
03/2024
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2024
1AmmoniaIBA
04/2023
1Complement System Proteins (Complement)IBA
03/2023
1VaccinesIBA
03/2023
1Trastuzumab (Herceptin)FDA Link
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1human ERBB2 proteinIBA
01/2022
1pertuzumabIBA
01/2022
1trastuzumab deruxtecanIBA
01/2022
1Prothrombin (Factor II)IBA
12/2021
1AntigensIBA
12/2021
1PlasminogenIBA
12/2021
1Antifibrinolytic Agents (Antifibrinolytics)IBA
12/2021
1fibrin fragment D (D-dimer)IBA
12/2021
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
12/2021
1von Willebrand FactorIBA
12/2021
1Interleukin-6 (Interleukin 6)IBA
12/2021
1Arginine Vasopressin (Argipressin)IBA
10/2021
1AngiotensinsIBA
10/2021

Therapy/Procedure

12Drug Therapy (Chemotherapy)
01/2011 - 04/2002
7Therapeutics
01/2022 - 04/2002
2Combination Drug Therapy (Combination Chemotherapy)
03/2005 - 10/2004
1Extracorporeal Membrane Oxygenation
03/2024
1Percutaneous Coronary Intervention
10/2022